A detailed history of Callan Capital, LLC transactions in Sanofi stock. As of the latest transaction made, Callan Capital, LLC holds 12,900 shares of SNY stock, worth $668,736. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,900
Previous 14,713 12.32%
Holding current value
$668,736
Previous $848,000 26.65%
% of portfolio
0.05%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

SELL
$45.89 - $57.31 $83,198 - $103,903
-1,813 Reduced 12.32%
12,900 $622,000
Q3 2024

Nov 12, 2024

BUY
$48.54 - $58.53 $235,952 - $284,514
4,861 Added 49.34%
14,713 $848,000
Q2 2024

Aug 12, 2024

BUY
$45.39 - $50.36 $212,652 - $235,936
4,685 Added 90.67%
9,852 $478,000
Q1 2024

Oct 22, 2024

SELL
$45.75 - $52.48 $214,338 - $245,868
-4,685 Reduced 47.55%
5,167 $251,000
Q1 2024

May 03, 2024

BUY
$45.75 - $52.48 $236,390 - $271,164
5,167 New
5,167 $251,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.